<DOC>
	<DOCNO>NCT00458575</DOCNO>
	<brief_summary>The main purpose study evaluate preliminary safety immunogenicity ( ability antigen provoke immune response human body ) CNTO 2476 , administer subretinally , participant advance retinitis pigmentosa ( RP ; disease eye lead loss vision blindness ) either light perception ( LP ) hand motion ( HM ) .</brief_summary>
	<brief_title>A Study Evaluate Safety CNTO 2476 Patients With Advanced Retinitis Pigmentosa</brief_title>
	<detailed_description>The study open-label ( people know identity intervention ) , first human safety study . Nine adult men woman advance RP LP ( first 5 participant ) good HM bilaterally ( subsequent 4 participant ) eye enrol . Participant 5 may combination visual acuity LP treat eye well HM fellow eye . Treatment proceed cohort basis ie , Cohort I : Participant 1 ; Cohort II : Participant 2 ; Cohort III : Participant 3 4 ; Cohort IV : Participant 5 , 6 , 7 ; Cohort V : Participant 8 9 . The initial participant cohort must complete least 4 week post-treatment follow-up participant next cohort may treat . There 2 safety assessment phase study : main phase approximately 12 month time participant eligible enter study long-term safety follow-up phase 4 additional year . The total length participation study could last 5 year ( include main safety follow-up phase ) .</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<criteria>Confirmed diagnosis retinitis pigmentosa part another systemic disease Vision deficit characterize vision well either light perception ( Group 1 ) hand motion ( Group 2 ) eye Normal hematology chemistry lab result Participant suitable candidate ophthalmologic surgery Other significant ophthalmologic disease ophthalmologic condition interfere ophthalmologic examination Women childbearing potential Ocular hypertension Other serious medical condition</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Advanced retinitis pigmentosa ( RP )</keyword>
	<keyword>CNTO 2476</keyword>
	<keyword>Subretinal</keyword>
	<keyword>Human umbilical tissue-derived cell ( hUTC )</keyword>
	<keyword>Light perception ( LP )</keyword>
	<keyword>Hand motion ( HM )</keyword>
</DOC>